WeVote

Bill

Bill

S 3643

Requires ingredients of menstrual products to be listed on package.

2024-2025 Regular Session Introduced by Renee Burgess and 4 co-sponsors

New Jersey bill requires menstrual product manufacturers to disclose all ingredients on packaging, giving consumers transparency about product contents previously undisclosed.

Reported out of Senate Committee, 2nd Reading
0
WeVote Research Nonpartisan
Bill Summary · S 3643

Legislative bill overview

S 3643 mandates that manufacturers disclose all ingredients used in menstrual products on package labeling, similar to requirements for food and cosmetics. The bill applies to tampons, pads, and other menstrual products sold in New Jersey and would give consumers direct access to ingredient information at point of purchase.

Why is this important

Many menstrual product users are unaware of what chemicals and materials their products contain, raising concerns about potential skin irritation, allergic reactions, and long-term health effects. Currently, menstrual products are largely unregulated by the FDA, and manufacturers are not required to disclose ingredients, leaving consumers without transparent information to make informed purchasing decisions.

Potential points of contention

  • Manufacturing burden and costs: Requiring reformulation of packaging and potentially product testing could increase production costs that manufacturers may pass to consumers, affecting affordability of an essential product
  • Trade secrets and competitive advantage: Manufacturers may argue that disclosing all ingredients reveals proprietary formulations and competitive formulas to rival companies
  • Regulatory scope debate: Questions about whether state-level regulation is appropriate or if federal FDA oversight would be more effective; unclear how this applies to out-of-state manufacturers or online sales

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.